Methods, compositions, and devices for supplying dietary fatty acid needs
Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.
1. A handheld device for providing a nutritional formula comprising monoglycerides and free fatty acids by temporarily exposing a nutritional composition comprising long-chain polyunsaturated fatty acid (LC-PUFA) triglycerides and/or LC-PUFA esters to lipase prior to ingestion, the device comprising:
a container defining an interior for receiving the nutritional composition;
a structure in fluid communication with the interior of the container; and
a lipase immobilized by covalent binding to the structure so that the nutritional composition is exposed to the lipase when the nutritional composition is received within the container;
wherein the covalent binding limits the amount of lipase that leaches into the nutritional composition when the nutritional composition is exposed to the lipase.
2. The device of claim 1 , further comprising an opening in the container for allowing the nutritional composition to enter the container.
3. The device of claim 2 , wherein the container further comprises a second opening in the container for allowing the nutritional formula to exit the container.
4. The device of claim 1 , wherein the device is a feeding mechanism.
5. The device of claim 4 , wherein the device is a bottle.
6. The device of claim 1 , wherein the structure comprises particles within the container.
7. The device of claim 6 , wherein the particles comprise balls or beads.
8. The device of claim 7 , wherein the particles are magnetic.
9. The device of claim 1 , wherein the structure comprises an inner surface of the container.
10. The device of claim 1 , wherein the structure comprises a wall of the container, and the lipase is immobilized on or contained within the wall of the container.
11. The device of claim 1 , wherein the structure is included as part of a separate compartment within the container.
12. The device of claim 1 , wherein the container includes an opening, wherein the structure comprises a removable cap of the container, wherein the cap is configured to seal the opening when affixed to the container, and wherein the cap comprises at least one lipase immobilized on or in a surface positioned for fluid contact with the interior when the cap seals the opening.
13. The device of claim 12 , wherein the structure comprises a projection extending from a surface of the cap that faces the interior of the container when the cap seals the opening.
14. The device of claim 1 , wherein the structure comprises projections within the container.
15. The device of claim 1 , wherein the lipase is encapsulated in a material that is permeable to fatty acids but is not permeable to the lipase.
16. The device of claim 1 , further comprising a valve.
17. The device of claim 1 , wherein the lipase is selected from the group consisting of Chromobacterium viscosum lipase, Pseudomonas fluorescens lipase, and Rhizopus oryzae lipase.
18. The device of claim 1 , wherein the lipase is immobilized within the container such that when the nutritional formula exits the container, the lipase remains in the container.
19. The device of claim 18 , further comprising a material that acts as a screen or a filter to prevent the lipase from exiting the device with the nutritional formula.
20. The device of claim 1 , further comprising a winding flow path configured to prolong exposure of the lipase to the nutritional formula contained within the flow path.
21. The device of claim 1 , wherein the container has walls that are permeable to the nutritional composition but are not permeable to the lipase.
22. The device of claim 1 , wherein the container has an inner wall defining a compartment in the interior and an outer wall defining the container, wherein the inner wall is permeable to the nutritional composition but is not permeable to the lipase.
23. The device of claim 1 , wherein the container is compressible.
24. A point-of-care device for providing a nutritional formula comprising monoglycerides and free fatty acids by temporarily exposing a nutritional composition comprising long-chain polyunsaturated fatty acid (LC-PUFA) triglycerides and/or LC-PUFA esters to lipase prior to ingestion, the device comprising:
a container defining an interior for receiving the nutritional composition;
a structure in fluid communication with the interior of the container; and
a lipase immobilized by covalent binding to the structure so that the nutritional composition is exposed to the lipase when the nutritional composition is received within the container of the point-of-care device;
wherein, during exposure of the nutritional composition to the lipase, the covalent binding limits the amount of lipase that is released into the nutritional composition to no more than 0.1 milligram of lipase per milligram of LC-PUFA exposed to the lipase.
25. The device of claim 24 , further comprising an opening in the container for allowing the nutritional composition to enter the container.
26. The device of claim 25 , wherein the container further comprises a second opening in the container for allowing the nutritional formula to exit the container.
27. The device of claim 24 , wherein the structure comprises particles within the container.
28. The device of claim 27 , wherein the particles comprise balls or beads.
29. A point-of-care device for providing a nutritional formula comprising monoglycerides and free fatty acids by temporarily exposing a nutritional composition comprising long-chain polyunsaturated fatty acid (LC-PUFA) triglycerides and/or LC-PUFA esters to lipase prior to ingestion, the device comprising:
a container defining an interior for receiving the nutritional composition;
a structure in fluid communication with the interior of the container;
a lipase immobilized by covalent binding to the structure so that the nutritional composition is exposed to the lipase when the nutritional composition is received within the container; and
an opening in the container for allowing the nutritional formula to exit the container;
wherein the covalent binding limits the amount of lipase that exits the point-of-care device with the nutritional formula to no more than 0.1 milligram of lipase per milligram of LC-PUFA exposed to the lipase.
30. The device of claim 29 , wherein the structure comprises particles within the container.
31. The device of claim 30 , wherein the particles comprise balls or beads.